生殖ホルモンおよびタンパク質検査市場：市場規模（セグメント別）、シェア、規制、償還、予測（～2033年）

生殖ホルモンおよびタンパク質検査には、抗ミュラーホルモン（AMH）ラボ検査、エストラジオールラボ検査、プロゲステロンラボ検査、デヒドロエピアンドロステロン硫酸（DHEAS）ラボ検査、プロラクチンラボ検査、テストステロンラボ検査、黄体形成ホルモン（LH）ラボ検査、卵胞刺激ホルモン（FSH）ラボ検査などが含まれます。

生殖ホルモンおよびタンパク質検査は、男性および/または女性の生殖能力を評価するために実施され、低ゴナドトロピン性性腺機能低下症、高プロラクチン血症、毛様体機能障害、嚢胞性線維症、およびクラミジア・トラコマティスや淋菌などの性感染症などの特定の疾患に関連しています。

当レポートは、世界の生殖ホルモンおよびタンパク質検査市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、COVID-19の影響、地域、国別の動向などを提供しています。

目次

現在上市されている生殖ホルモンおよびタンパク質検査と競合情勢

• 主要な業界動向の洞察
• 生殖ホルモンおよびタンパク質検査のセグメント別総市場収益と2015年～2033年の市場展望
• 個数、平均販売価格、市場価値に関する詳細データ

世界、地域、国別の洞察

• 生殖ホルモンおよびタンパク質検査市場のSWOT分析
• 生殖ホルモンおよびタンパク質検査市場に関する競合力学の洞察と動向
• 国別の医療制度の概要
• 国別の償還政策
• 国別の医療技術に関する規制の状況

List of Tables

Not Applicable

List of Figures

Not Applicable

Abstract

Reproductive Hormones and Proteins Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.

The model discusses in detail the impact of COVID-19 on Reproductive Hormones and Proteins tests market for the year 2020 and beyond. The Reproductive Hormones and Proteins tests include

Anti-Mullerian Hormone (AMH) lab Test, Estradiol lab Test, Progesterone lab Test, Dehydroepiandrosterone Sulphate (DHEAS) lab Test, Prolactin lab Test, Testosterone lab Test, Luteinizing Hormone (LH) lab Test, and Follicle-Stimulating Hormone (FSH) lab Test.

Reproductive Hormones and Proteins tests are performed to evaluate fertility in men and/or women and is associated with specific diseases such as hypogonadotropic hypogonadism, hyperprolactinemia, ciliary function disorders, cystic fibrosis, and sexually transmitted infections such as Chlamydia trachomatis and Neisseria gonorrhoeae.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Reproductive Hormones and Proteins Tests and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Reproductive Hormones and Proteins Tests market revenue by segment and market outlooks from 2015- 2033.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Reproductive Hormones and Proteins Tests market.
• Competitive dynamics insights and trends provided for Reproductive Hormones and Proteins Tests market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Danaher Corp, Abbott Laboratories, Siemens AG, Quidelortho Corp, F. Hoffmann-La Roche Ltd, Tosoh Corp, and others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Reproductive Hormones and Proteins Tests marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Reproductive Hormones and Proteins Tests market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Reproductive Hormones and Proteins Tests market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Reproductive Hormones and Proteins Tests market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Track device sales in the global and country-specific Reproductive Hormones and Proteins Tests market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Table of Contents

Not Applicable